This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Company. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987
Title: Inventor Spotlight: Michael D. Thompson
Introduction
Michael D. Thompson, an innovative inventor based in Evansville, Indiana, has made significant contributions to the field of chemical compounds. He holds one patent that enhances the understanding and application of intermediates useful in the preparation of medically relevant compounds.
Latest Patents
Thompson's notable patent involves the disclosure of compounds represented by specific formulas, where R^1 and R^2 can take various forms such as hydrogen, lower alkyl groups, and phenyl groups, among others. These compounds are recognized for their utility as intermediates in the production of tiprinast and related pharmaceuticals. The patent also details a process for the regioselective synthesis of one of these compounds, specifically designed to facilitate reactions under acidic conditions.
Career Highlights
Currently, Thompson works at Bristol-Myers Squibb, a leading global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines. His work in developing chemical intermediates positions him as a valuable asset in the research and development of new therapeutic agents.
Collaborations
Throughout his career, Thompson has collaborated with several professionals, most notably with Gary D. Madding. This partnership has likely contributed to the successful development and patenting of his chemical innovations, showcasing the importance of teamwork in advancing scientific research.
Conclusion
Michael D. Thompson stands out as a dedicated inventor whose work has practical implications in the pharmaceutical industry. His patent not only represents an advancement in chemical intermediates but also underscores the importance of innovative research in developing effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
